Joubert syndrome-related disorders (JSRDs) are autosomal recessive pleiotropic conditions sharing a peculiar cerebellar and brainstem malformation known as the Ômolar tooth sign' (MTS). Recently, mutations in a novel ciliary gene, RPGRIP1L, have been shown to cause both JSRDs and Meckel-Gruber syndrome. We searched for RPGRIP1L mutations in 120 patients with proven MTS and phenotypes representative of all JSRD clinical subgroups. Two homozygous mutations, the previously reported p.T615P in exon 15 and the novel c.2268_2269delA in exon 16, were detected in 2 of 16 families with cerebello-renal presentation (12%). Conversely, no pathogenic changes were found in patients with other JSRD phenotypes, suggesting that RPGRIP1L mutations are largely confined to the cerebello-renal subgroup, while they overall represent a rare cause of JSRD (,2%). midbrain-hindbrain malformation evident on brain magnetic resonance that is characterized by hypo/dysplasia of the cerebellar vermis, elongated, thickened and maloriented superior cerebellar peduncles and a deep interpeduncular fossa (Ômolar tooth sign', MTS) (1) . Besides the typical neurological features of Joubert syndrome (JS, MIM213300), the organs most commonly affected are the kidneys and the retina, with nephronophthisis (NPH) and retinal dystrophy of variable severity. Based on these organs' involvement, four major JSRD subgroups are defined, namely pure JS, JS plus retinopathy (cerebelloretinal phenotype), JS plus renal involvement (cerebello-renal phenotype) and cerebello-oculorenal phenotype (COR). Additional clinical features can be found in all subgroups, including other central nervous system (CNS) malformations, chorioretinal colobomas, hepatic fibrosis, polydactyly, orofacial midline and laterality defects. Some of these features may co-occur in definite associations, such as COACH (JS plus colobomas and hepatic fibrosis, MIM216360) and orofaciodigital syndrome type VI (OFDVI, JS plus polydactyly and orofacial midline defects, MIM277170) (2) .
The phenotypic complexity of JSRDs mirrors their genetic heterogeneity. Two loci (JBTS1 and JBTS2) have been mapped to chromosomes 9 and 11, while mutations in AHI1, NPHP1, CEP290, MKS3 and, more recently, RPGRIP1L have been detected in JSRD patients with variable phenotypes. Adding more complexity, mutations in many JSRD genes have been found also to cause other ciliopathies, including isolated NPH (NPHP1), Senior-Løken syndrome (NPHP1 and CEP290), Leber congenital amaurosis (CEP290) and Meckel-Gruber syndrome (MKS3, CEP290, and RPGRIP1L) (2) .
Molecular screens of large cohorts of JSRD patients representative of all subgroups have been performed only for some genes, allowing the identification of valuable genotype-phenotype correlates. Mutations in CEP290 have been shown nearly invariable to cause the COR phenotype (3, 4) ; NPHP1 mutations have been detected in patients with JS always associated to renal involvement and occasionally with retinopathy (5) (6) (7) (8) , while AHI1 mutations cause either pure JS or JS plus retinopathy, with kidneys nearly always spared (9, 10) .
The RPGRIP1L gene was recently found mutated in about 8-10% of patients with cerebello-renal phenotype (11) (12) (13) , but its mutation frequency in the full spectrum of JSRDs has not been evaluated. In this study, we report the mutation analysis of this gene in a large cohort of clinically well-characterized JSRD patients and discuss genotype-phenotype correlates.
Materials and methods Patients
Mutation analysis was performed in a cohort of 120 JSRD patients recruited worldwide. In all cases, the clinical diagnosis was confirmed by neuroradiological demonstration of the MTS. Detailed clinical data were obtained by referring clinicians through a standardized questionnaire assessing the possible involvement of all organs, including CNS, retina, kidneys, liver and the occurrence of associated malformations. Data were collected at the CSS-Mendel Institute of Rome and at the University of California San Diego, and samples were obtained through referring physicians or the JS BioBank (http:// www.joubertsyndrome.org/BioBank.asp). Patients were divided into six different cohorts as follows: (i) 44 with pure JS; (ii) 24 with JS plus retinal involvement; (iii) 16 with JS plus renal involvement; (iv) 19 with COR phenotype; (v) 11 with COACH syndrome; and (vi) 6 with OFDVI syndrome.
Informed consent was obtained from all families, and the study was approved by the local ethics committees. Patients previously found to harbor mutations in NPHP1, AHI1, CEP290 or MKS3 were excluded from the screening.
Molecular analysis
Genomic DNA was extracted from peripheral blood lymphocytes following standard methods or obtained directly from referral centers. The whole RPGRIP1L (GenBank NM_015272) coding region (exons 2-27) was tested for mutations. Each exon including exon-intron junctions was polymerase chain reaction (PCR) amplified and then analyzed by means of denaturing highperformance liquid chromatography (DHPLC) using a Wave DNA fragment analysis system (Transgenomics, Crewe, United Kingdom) at column temperatures recommended by NAVIGATOR software v. 1.5.4 (Transgenomics) . Primers, PCR and DHPLC conditions are listed in Table 1 .
To preserve DNA from affected children and to overcome DHPLC limits in identifying homozygous nucleotide changes, DNA from both parents was analyzed in the screening. All exons showing abnormal elution profiles underwent bidirectional sequencing after purification of the PCR product (Millipore, Billerica, MA) by using BigDye chemistry and an ABI 3100 capillary array sequencer (Applied Biosystems, Foster City, CA). Segregation of mutations detected in healthy parents was evaluated by direct sequencing of the proband and other available family members.
Results
Two families in the cerebello-renal subgroup harbored mutations in RPGRIP1L, while no pathogenic changes were found in patients with other JSRD phenotypes. Single nucleotide polymorphisms and non-segregating variants of unknown significance are listed in Table 2 . Family A consisted of two affected siblings born from apparently non-consanguineous healthy parents of Swiss origin. Both siblings were homozygous and both parents were heterozygous for the c.1843A.C mutation in exon 15, resulting in the p.T615P missense change. While this work was in progress, the two sibs have been reported as part of a cohort of patients with NPH and JS (family F138 in 13), and we provide a more detailed description of their phenotype in this study.
The 22-year-old male proband and his younger sister presented developmental delay, growth and mental retardation, NPH and severe scoliosis. Visual acuity and fundus examination, as well as liver function, repeatedly tested normal in both patients. Several features presented marked intrafamilial variability, being detected either in the sister (post-axial polydactyly of hands, bilateral ptosis, and abnormal neonatal breathing) or in the proband (oculomotor apraxia). The degree of growth and psychomotor delay also differed widely between the two sibs, being much more severe in the sister. Indeed, she showed a dramatic failure to thrive, with body weight and height that had always been well below the third centile. She never achieved the abilities to stand unaided and to produce expressive language, was always fully dependent for daily life activities and died at the age of 17.5 years from end-stage renal failure. Conversely, the proband reached independent walking at 30 months and attended a special school where he acquired many skills of daily life, becoming nearly self-sufficient. He underwent kidney transplant at age 11 years, which is still functioning well, and surgical treatment for severe scoliosis at age 18 years. His growth parameters are within the normal limits.
The second mutated family (B) consisted of a 4-year-old affected female born from first-cousin healthy parents of Moroccan origin. She was homozygous for a c.2268_2269delA mutation in exon 16, resulting in frameshift and premature protein truncation (p.I756fsX769). At birth, she presented occipital meningoencephalocele that was surgically removed, bilateral post-axial polydactyly of hands and feet, clubfoot and right-sided inguinal hernia. Several episodes of hyperpnea followed by periods of apnea were recorded, and her milestones were severely delayed along with a marked failure to thrive. Renal dysfunction became manifested at age 1 year when she was hospitalized for an episode of acute increase of plasma creatinine levels and reduced glomerular filtration. Kidney ultrasounds repeatedly showed small kidneys with increased echogenicity, loss of corticomedullary differentiation and multiple cysts compatible with NPH. Ocular examination showed horizontal nystagmus and alternating internal strabismus, while other investigations including fundoscopy were negative. Now, at age 4 years, the patient presents chronic renal failure, marked growth retardation (body weight, height and head circumference well below the third centile) and severe psychomotor delay, with Common, allele frequency greater than 2%; n.s., variation found in the parent but not segregating in affected offspring; SNP, single nucleotide polymorphism.
lack of head control and inability to speak any meaningful word. Affected members from both families presented the typical MTS (Fig. 1) .
Discussion
In this study, we performed mutation analysis of the RPGRIP1L gene in a cohort of 120 patients with proven MTS, comprehensive of the whole JSRD clinical spectrum. We identified pathogenic mutations only in 2 of 16 families with cerebellorenal phenotype, leading to a 12% frequency in this specific clinical subgroup, in line with previous data (13) . Conversely, pathogenic mutations were not detected in patients presenting with pure JS, JS plus retinopathy, COR, COACH and OFDVI syndromes, thus making RPGRIP1L a rare genetic cause of JSRDs (,2%). Overall, these data support the existence of a correlate between this gene and the cerebello-renal presentation. Indeed, such phenotype has been found in 13 of the 18 RPGRIP1L-mutated JSRD patients so far described (11-13, this study) . In the remaining five cases, three had pure JS, yet they were all young (1, 3 and 5 years) and still at risk to develop renal disease later in life; the other two patients presented atypical phenotypes with possible retinal involvement but no proven MTS (12, 13) .
The other major gene causative of JS plus renal involvement is NPHP1, with mutation frequencies also in the range of 5-14% (5-8) . Nevertheless, some differences can be observed when comparing NPHP1-and RPGRIP1L-associated phenotypes. Firstly, the MTS aspect in NPHP1-deleted patients appears to be consistently Ômild', with superior cerebellar peduncles that are elongated but not thickened, at difference with RPGRIP1L patients presenting a classical MTS (Fig. 1) . Secondly, NPHP1 is nearly invariably associated with juvenile NPH, while RPGRIP1L mutations have been shown to cause both the infantile and the juvenile forms of NPH. Thirdly, liver involvement, encephalocele and severe scoliosis have been reported in a number of patients with RPGRIP1L mutations but never in association with NPHP1. Finally, retinal involvement is detected in about one-third of NPHP1 patients, while it has been reported only in 2 of 18 RPGRIP1L cases. In the first patient (F491-1 in 12), only one heterozygous missense change could be identified, and it is possible that unidentified mutations in other genes could contribute to his phenotypic diversity. The other patient (A166, II-3 in 13), homozygous for the p.T615P mutation, has been reported with unspecified Ôvision problems', but it is currently unclear whether these could result from an underlying retinal degeneration.
The rare association of RPGRIP1L mutations with retinal defects is worthy of note because mutations in the closely related RPGRIP1 gene account for about 6% of isolated Leber congenital amaurosis, one of the commonest genetic causes of visual impairment at birth (14, 15) . A plausible hypothesis is that the two homologue genes may have complementary and partially redundant functions in specific tissues, that is, the kidneys and the retina, respectively. So far, 16 different RPGRIP1L mutations have been described. About half of them cluster in exon 15, including p.T615P, that is the only mutation recurring in five unrelated families. Thus, exon 15 likely represents a mutational hot spot and deserves molecular investigation in patients with cerebello-renal JSRD. The second mutation reported in this study is novel and is the first so far described in RPGRIP1L exon 16. This homozygous 1-bp deletion is predicted to cause premature protein termination before the second C2 domain and is the second homozygous truncating mutation so far reported in JSRD patients (11) . Hence, such mutations are associated not only with Meckel-Gruber syndrome but also with JSRD phenotypes comparable to those caused by missense changes. This finding argues against the proposed correlation between complete loss of function of the protein and more severe clinical syndromes (12) and underlies the existence of still unknown genetic modifiers.
The presence of possible epistatic effects is further highlighted by the phenotypic variability observed within some RPGRIP1L-mutated families. For instance, patient A166,II-3 reported by Wolf et al. (13) presented with mental retardation, NPH and impaired vision in the absence of cerebellar vermis hypoplasia and MTS, while this malformation was detected in her 5-year-old brother with developmental delay and NPH. Similarly, intrafamilial variability was observed in our family A regarding several clinical features such as polydactyly, oculomotor apraxia, growth and psychomotor delay.
In conclusion, significant correlates are emerging between JSRD causative genes and specific clinical phenotypes despite the wide genetic heterogeneity. The exclusion of RPGRIP1L mutations in patients within most JSRD subgroups strengthens the correlation between this gene and the cerebello-renal presentation.
